Elicio Therapeutics, Inc. (ELTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.65M | 25.94M | 1.46M | 540K | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | - | 5551.63% | 76.54% | - | - |
| Cost of Goods Sold | 289K | 0 | 0 | 0 | 278K | 305K | 290K | 293K | 290K | 286K | 0 | 0 | 0 | 294K | 0 | 228K | 656K | 217K | 206K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.84% | 2.53% | 14.86% | 38.15% | - |
| Gross Profit | -289K | 0 | 0 | 0 | -278K | -305K | -290K | -293K | -290K | -286K | 0 | 0 | 0 | -294K | 0 | 1.42M | 25.29M | 1.24M | 334K | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 86.17% | 97.47% | 85.14% | 61.85% | - |
| Gross Profit Growth % | -3.96% | 100% | 100% | 100% | 4.14% | -6.64% | - | - | - | 2.72% | - | - | -100% | -101.16% | -100% | - | 13421.39% | 267.75% | - | - |
| Operating Expenses | 10.31M | 8.84M | 8.04M | 10.09M | 10.46M | 13.17M | 10.05M | 10.63M | 9.95M | 9.11M | 10.77M | 7.78M | 7.8M | 5.67M | 5.77M | 15.9M | 10.65M | 17M | 18.58M | 6.19M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 965.11% | 41.06% | 1164.45% | 3440.37% | - |
| Selling, General & Admin | 3.85M | 3.76M | 3.01M | 3.08M | 2.96M | 2.55M | 3.14M | 2.74M | 2.68M | 3.23M | 3.51M | 2.83M | 2.32M | 1.67M | 1.18M | 4.27M | 4.01M | 3.74M | 4.16M | 1.64M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 259.1% | 15.48% | 256.37% | 769.81% | - |
| Research & Development | 6.71M | 5.08M | 5.04M | 7.01M | 7.78M | 10.62M | 7.21M | 8.18M | 7.56M | 6.16M | 7.26M | 4.94M | 5.48M | 4M | 4.59M | 11.63M | 6.64M | 13.26M | 14.42M | 4.55M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 706.01% | 25.58% | 908.08% | 2670.56% | - |
| Other Operating Expenses | -243K | 0 | 0 | 0 | -278K | 0 | -290K | -293K | -290K | -286K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.6M | -8.84M | -8.04M | -10.09M | -10.74M | -13.48M | -10.34M | -10.92M | -10.24M | -9.39M | -10.77M | -7.78M | -7.8M | -5.96M | -5.77M | -14.48M | 14.63M | -15.76M | -18.24M | -6.19M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -878.94% | 56.41% | -1079.32% | -3378.52% | - |
| Operating Income Growth % | 1.25% | 34.39% | 22.23% | 7.63% | -4.83% | -43.48% | 3.96% | -40.47% | -31.21% | -57.56% | -86.67% | - | 46.12% | -140.73% | 63.38% | -133.9% | 205.66% | -36.02% | - | - |
| EBITDA | -10.31M | -8.56M | -7.76M | -9.81M | -10.46M | -13.17M | -10.05M | -10.63M | -9.95M | -9.11M | -10.5M | -7.28M | -7.7M | -5.67M | -5.48M | -14.26M | 14.86M | -15.54M | -18.04M | -6.14M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -865.11% | 57.27% | -1064.45% | -3340.37% | - |
| EBITDA Growth % | 1.39% | 35.04% | 22.8% | 7.72% | -5.1% | -44.64% | 4.23% | -46.11% | -29.32% | -60.68% | -91.71% | - | 46.03% | -138.14% | 64.76% | -132.18% | 208.41% | -35.8% | - | - |
| D&A (Non-Cash Add-back) | 289K | 286K | 283K | 281K | 278K | 305K | 290K | 293K | 290K | 286K | 273K | 501K | 110K | 294K | 294K | 228K | 223K | 217K | 206K | 52.3K |
| EBIT | -10.6M | -7.38M | -9.66M | -10.37M | -11.03M | -13.77M | -18.7M | -7.18M | -11.79M | -8.95M | -10.66M | -6.84M | -7.69M | -6.56M | -6.12M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
| Net Interest Income | -250K | -138K | -227K | -26K | 34K | 71K | 48K | 88K | 114K | 73K | 245K | -675K | -332K | -36.01K | -1.07M | 1.36M | 876.25K | 110K | 124K | 1.8K |
| Interest Income | 157K | 199K | 199K | 168K | 210K | 305K | 185K | 137K | 150K | 75K | 246K | 39K | 10K | 54.83K | 10K | 1.36M | 876.25K | 110K | 124K | 1.8K |
| Interest Expense | 407K | 337K | 426K | 194K | 176K | 234K | 137K | 49K | 36K | 2K | 1K | 714K | 342K | 90.84K | 1.08M | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -1.22M | 1.12M | -2.04M | -470K | -473K | -528K | -8.49M | 3.69M | -1.59M | 443K | 113K | 218K | -224K | -690K | -1.43M | 245K | 256K | 54K | 1.17M | 1.8K |
| Pretax Income | -11.82M | -7.72M | -10.08M | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M | -8.03M | -6.65M | -7.2M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -864.08% | 57.4% | -1075.62% | -3161.48% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -11.82M | -7.72M | -10.08M | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M | -8.03M | -6.65M | -7.2M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -864.08% | 57.4% | -1075.62% | -3161.48% | - |
| Net Income Growth % | -5.48% | 44.89% | 46.48% | -46.09% | 5.23% | -56.49% | -76.75% | 4.37% | -47.3% | -34.55% | -48.07% | - | 43.62% | -144.67% | 54.16% | -130.01% | 151.57% | 11.12% | - | - |
| Net Income (Continuing) | -11.82M | -7.72M | -10.08M | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M | -8.03M | -6.65M | -7.2M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.65 | -0.45 | -0.60 | -0.66 | -0.87 | -1.15 | -1.39 | -0.64 | -1.15 | -0.93 | -2.61 | -2.44 | -2.51 | -2.15 | -2.27 | -4.75 | 4.97 | -5.26 | -5.75 | -0.47 |
| EPS Growth % | 25.29% | 60.87% | 56.83% | -3.13% | 24.35% | -23.66% | 46.74% | 73.77% | 54.18% | 56.74% | -14.98% | - | 47.16% | -143.26% | 56.84% | -910.64% | 228.42% | -121.94% | - | - |
| EPS (Basic) | -0.65 | -0.45 | -0.60 | -0.66 | -0.87 | -1.15 | -1.39 | -0.64 | -1.15 | -0.93 | -2.61 | -2.44 | -2.51 | -2.15 | -2.27 | -4.75 | 4.97 | -5.26 | -5.75 | -0.47 |
| Diluted Shares Outstanding | 18.21M | 15.31M | 16.69M | 16.06M | 12.95M | 12.2M | 13.58M | 11.28M | 10.27M | 9.6M | 4.08M | 3.1M | 3.2M | 3.1M | 3.18M | 3M | 3M | 2.98M | 2.97M | 13.31M |
| Basic Shares Outstanding | 18.21M | 15.31M | 16.69M | 16.06M | 12.95M | 12.2M | 13.58M | 11.28M | 10.27M | 9.6M | 4.08M | 3.1M | 3.2M | 3.1M | 3.18M | 3M | 3M | 2.98M | 2.97M | 13.31M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |